D000085Chemicals & DrugsD02.241.081.038.208.0259150.991682AcetatesFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.5462910.03364099research area of0.620940.05675624subject area forAnesthesiologyEmergency MedicineWake Forest School of MedicineAnthonyBleyerAnthony J. Bleyer MD, MS36.08959100000000-80.2685990000000010Bleyer, AnthonyProfessorWendyMooreWendy C. Moore MD36.09040200000000-80.267005999999991041Moore, WendyProfessorStephenPetersStephen Peters MD, PhD36.09040200000000-80.26700599999999927Peters, StephenProfessor26083242Dahlin A, Litonjua A, Lima JJ, Tamari M, Kubo M, Irvin CG, Peters SP, Tantisira KGPloS oneDahlin A, Litonjua A, Lima JJ, Tamari M, Kubo M, Irvin CG, Peters SP, Tantisira KG. Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma. PLoS One. 2015; 10(6):e0129385.PLoS One2015-06-17T00:00:002015Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma.27814453Kaminsky DA, Wang LL, Bates JH, Thamrin C, Shade DM, Dixon AE, Wise RA, Peters S, Irvin CGAmerican journal of respiratory and critical care medicineKaminsky DA, Wang LL, Bates JH, Thamrin C, Shade DM, Dixon AE, Wise RA, Peters S, Irvin CG. Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma. Am J Respir Crit Care Med. 2017 Apr 15; 195(8):993-999.Am J Respir Crit Care Med2017-04-15T00:00:002017Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma.RobertHurleyRobert W. Hurley MD, PhD36.09003100000000-80.268028000000002163Hurley, RobertProfessor20ProfessorInternal Medicine, NephrologyInternal Medicine, Pulmonary, Critical Care, Allergy and Immunologic Diseasestrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor18971019Bleyer AJAmerican journal of kidney diseases : the official journal of the National Kidney FoundationBleyer AJ. Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study. Am J Kidney Dis. 2008 Nov; 52(5):1024; author reply 1025.Am J Kidney Dis2008-11-01T00:00:002008Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.20709517Djukanovic R, Wilson SJ, Moore WC, Koenig SM, Laviolette M, Bleecker ER, Davis WB, Doherty DE, Olivenstein R, Israel E, Kavuru MS, Kleerup E, Reilly DS, Yancey SW, Edwards LD, Stauffer JL, Dorinsky PM, Jarjour NNRespiratory medicineDjukanovic R, Wilson SJ, Moore WC, Koenig SM, Laviolette M, Bleecker ER, Davis WB, Doherty DE, Olivenstein R, Israel E, Kavuru MS, Kleerup E, Reilly DS, Yancey SW, Edwards LD, Stauffer JL, Dorinsky PM, Jarjour NN. Montelukast added to fluticasone propionate does not alter inflammation or outcomes. Respir Med. 2010 Oct; 104(10):1425-35.Respir Med2010-08-14T00:00:002010Montelukast added to fluticasone propionate does not alter inflammation or outcomes.22029858Drummond MB, Peters SP, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA, Sugar EAThe Journal of asthma : official journal of the Association for the Care of AsthmaDrummond MB, Peters SP, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA, Sugar EA. Risk factors for montelukast treatment failure in step-down therapy for controlled asthma. J Asthma. 2011 Dec; 48(10):1051-7.J Asthma2011-10-27T00:00:002011Risk factors for montelukast treatment failure in step-down therapy for controlled asthma.ChristopherWatkinsChristopher B. Watkins DO36.08862300000000-80.268210999999991489Watkins, ChristopherAssistant Professor